Although ERα had been reported to activate RERG gene expression, we found that lower RERG was significantly associated with poorer OS and DFS in both ERα (+) and ERα (−) breast cancer subtypes (Supplementary Table S2 and S3). This evidence concerns the gene ESR1 and breast carcinoma.